General AML

1st NCRI AML academy meeting | Can the new treatments for AML reduce the need for allo-HSCT?

L: English

During the 1st NCRI AML academy meeting, the AML Global Portal was pleased to speak to Dr Mike Dennis from the Christie NHS Foundation Trust, Manchester, UK, who discussed how the new therapies that are now licensed for the treatment of AML may reduce the need for allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Was this article informative? Thank you for your feedback!
100% of people found this article informative